• KOL
    • Hyperactivity Disorder
    • David Sugrue
    • David Sugrue: Influence Statistics

      David Sugrue

      David Sugrue

      David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      David Sugrue:Expert Impact

      Concepts for whichDavid Sugruehas direct influence:Hyperactivity disorder,Deficit hyperactivity,Disorder hyperactivity,Disorder adhd,Methylphenidate tablets,Nervous stimulants,Stimulants child,Humans methylphenidate.

      David Sugrue:KOL impact

      Concepts related to the work of other authors for whichfor which David Sugrue has influence:Excessive blinking,Hyperactivity disorder,Laboratory classroom setting,Dopamine compartmentalization,Mpd adulthood,Adults adhd,Young brain.

      KOL Resume for David Sugrue

      Year
      2014

      David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate Professor of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs

      Sample of concepts for which David Sugrue is among the top experts in the world.
      Concept World rank
      methylphenidate tablets #98

      Prominent publications by David Sugrue

      KOL-Index: 4620

      PURPOSE: Current literature on the safety and efficacy of various intermediate- and long-acting preparations of methylphenidate and dexmethylphenidate for pediatric attention-deficit/hyperactivity disorder (ADHD) is reviewed.

      SUMMARY: The efficacy of methylphenidate in controlling ADHD symptoms is firmly established. Given the drug's relatively short half-life in pediatric patients (about 2.5 hours), a number of intermediate- and long-acting products have been developed; these ...

      Known for Hyperactivity Disorder | Adhd Symptoms | Attention Deficit | Extended Release | Methylphenidate Tablets

      Key People For Hyperactivity Disorder

      Top KOLs in the world
      #1
      JOSEPH Biederman
      bipolar disorder attention deficit adults adhd
      #2
      Stephen V Faraone∗
      hyperactivity disorder attention deficit children adhd
      #3
      Thomas J Spencer
      hyperactivity disorder attention deficit adults adhd
      #4
      Russell A Barkley
      hyperactivity disorder attention deficit hyperactive children
      #5
      James M Swanson
      hyperactivity disorder children adhd attention deficit
      #6
      Jan K Buitelaar∗
      hyperactivity disorder attention deficit adhd symptoms

      David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate Professor of Pharmacy Practice, School of Pharmacy, University of Connecticut

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.